Skip to content

Oral Mucosal Graft Versus Labial Graft in Female Urethroplasty

Oral Mucosal Graft Versus Labial Graft in Female Urethroplasty: A Prospective Comparative Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07153861
Enrollment
40
Registered
2025-09-04
Start date
2025-02-26
Completion date
2026-01-01
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female, Labial Graft, Oral Mucosal Graft, Urethroplasty

Brief summary

This study aims to compare the oral versus labial graft in female urethroplasty in female urethral stricture.

Detailed description

Female urethral stricture is an uncommon condition with an estimated prevalence of 4%-13% in women with bladder outlet obstruction. Urethral reconstruction may become the treatment of choice in stricture recurrence following the failure of minimally invasive procedures. and the use of flaps and grafts has all been proposed. Different materials (e.g., vaginal and genital mucosal graft or flap, bladder mucosal flap, and oral mucosal graft) have been reported for augmentation urethroplasty.

Interventions

Patients will be admitted for the surgical management by the oral mucosal graft urethroplasty with the anterior onlay technique.

PROCEDURELabial graft

Patients will be admitted for the surgical management by the labial graft urethroplasty with the anterior onlay technique.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female patients with urethral stricture. * Female patients with non-traumatic urethral stricture.

Exclusion criteria

* Female patients with traumatic urethral stricture. * Female patients with systemic contraindications of surgery like bleeding disorders.

Design outcomes

Primary

MeasureTime frameDescription
Urine flow rate6 months post-procedureUrine flow rate will be recorded.

Countries

Egypt

Contacts

Primary ContactElmaadawy I Elmaadawy, MD
Mohamed.elmaadawy@med.tanta.edu.eg00201060245430

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026